Celldex Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$38.06

-0.43 (-1.10%)

As of Aug 8, 1:39 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 20 91%

Hold 2 9%

Sell 0 0%

Price Target

Analyst Price Target +36.8% upside

Low Target $39.61

Average Target $52.08

High Target $81.09

Current Price $38.06

Current
$38.06

Target
$52.08

$39.61 $52.08 avg $81.09

Scenario Analysis

Bear Case

$39.61

4.1%

Low target

Base Case

$52.08

+36.8%

Avg target

Bull Case

$81.09

+113.1%

High target

Risk/Reward

27.8x

Highly favorable

Price in Context

52-Week High

$41.74

-8.8% from high

52-Week Low

$19.72

+93.0% from low

Target vs 52W High

$52.08

+24.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	79%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	44	64%	$91.45	-56.0%